Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03819179 · ClinicalTrials.gov registry record · NA
The Influence of Personal Care Products on the Skin Microbiome
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03819179: Completed NA study, sponsored by University of California, Davis.
NCT03819179 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03819179, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
To evaluate whether personal care products shift the skin microbiome bacteria and diversity after a week of daily use.
Primary Outcome
Cotton swabs will be used to collect sample skin microbiome bacteria from the cheeks and forehead at baseline and 1 week after daily use of the intervention product. These samples will be analysed and the relative components of the microbiome will be a primary outcome.The collected measurement data will be based on a number of operational taxonomic unit (OTU).
Interventions
- OTHER Burt's Bees Serum
- OTHER Burt's Bees Serum with Biulin
- OTHER Burt's Bees Serum with Bonicell
- OTHER Burt's Bees Serum with Berenew Complex
- OTHER Burt's Bees Serum with Ecoskin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2018-02-06 |
| Phase | NA |
What the finished NCT03819179 record still lists
NCT03819179 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which Burt's Bees Serum is the first listed.
NCT03819179 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03819179 about?
NCT03819179 is a clinical study titled "The Influence of Personal Care Products on the Skin Microbiome". To evaluate whether personal care products shift the skin microbiome bacteria and diversity after a week of daily use.
What is the current status of trial NCT03819179?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-12-01. Estimated completion is 2018-02-06.
What interventions are being tested in trial NCT03819179?
The interventions under investigation include: Burt's Bees Serum (OTHER), Burt's Bees Serum with Biulin (OTHER), Burt's Bees Serum with Bonicell (OTHER), Burt's Bees Serum with Berenew Complex (OTHER), Burt's Bees Serum with Ecoskin (OTHER).
Who is sponsoring clinical trial NCT03819179?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03819179's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI